Skip to content
10-Q

Quarterly Report

MJ Pharmaceuticals Inc.

0001185185-14-002049

← back to feed
Filed
Aug 11, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Jun 30, 2014 160.12M sh
Operating Cash Flow Q2 2014 · Jun 30, 2014 −$12.51K
Operating Cash Flow Q2 2014 · Jun 30, 2013 $0
Stockholders Equity Q2 2014 · Jun 30, 2014 $3.5K
Current Liabilities Q2 2014 · Jun 30, 2014 $0
Current Liabilities Q2 2014 · Dec 31, 2013 $0
Current Assets Q2 2014 · Jun 30, 2014 $3.5K
Current Assets Q2 2014 · Dec 31, 2013 $0
Total Assets Q2 2014 · Jun 30, 2014 $3.5K
Total Assets Q2 2014 · Dec 31, 2013 $0
Net Income Q2 2014 · Jun 30, 2014 −$12.51K
Net Income Q2 2014 · Jun 30, 2013 $0
Net Income Q2 2014 · Jun 30, 2013 $0
Revenue Q2 2014 · Jun 30, 2014 $0
Revenue Q2 2014 · Jun 30, 2014 $0
Revenue Q2 2014 · Jun 30, 2014 $0
Revenue Q2 2014 · Jun 30, 2013 $0
Revenue Q2 2014 · Jun 30, 2013 $0
Cash And Equivalents Q2 2014 · Jun 30, 2013 $0
Cash And Equivalents Q2 2014 · Dec 31, 2012 $0
Eps Basic Q2 2014 · Jun 30, 2013 $0.00
Eps Basic Q2 2014 · Jun 30, 2013 $0.00